AUS
NZ
UK
CA
USA
IND
Healt
A look at 2 ASX-listed dental care stocks: SDI, PSQ
May 31, 2022 11:54 AM AEST| By Aditi SarkarHighlights Private dental clinics cater to more than 85% of dental care in Australia. Dental care stock SDI, which registered record 1H sales, expects new product releases and continued increases in market share to underpin growth momentum. CO.....
RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years
May 28, 2022 12:45 AM AEST| By Aditi SarkarMultibaggers are lucrative stocks that provide returns several times higher than their initial investment value. To be more specific, if a stock price rises by double, it's called a double bagger, while if the price grows multiple times, it's calle.....
From REG to ICR: Latest updates from ASX-listed aged care stocks
May 26, 2022 07:37 PM AEST| By Aditi SarkarHighlights The Australian government provides funding to a range of aged care homes Regis Healthcare provides care for over 7,200 people throughout Australia Swift Networks has secured a new agreement worth AU$1.5 million with Hubify Limited .....
Volpara Health (ASX:VHT) exceeds revenue guidance in FY22
May 26, 2022 12:13 PM AEST| By Sonal GoyalHighlights Volpara marked 32% increase in revenue from customer contracts to NZ$26.1 million. Volpara delivered gross profit margin of over 91% in FY22. Volpara recorded 45% surge in the cash receipts. Health care technology provider, Vol.....
ALT and CDX: Why these ASX healthcare stocks were in news today
May 18, 2022 05:55 PM AEST| By Aditi SarkarHighlights The S&P/ASX 200 Health Care (AXHJ) is up today with a gain of 0.235% Shares of ALT ended Wednesday with an upsurge of 50% following the approval of European and Indian patents CardieX's CONNEQT Companion app gets an MDDS classif...
WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns
May 17, 2022 10:52 AM AEST| By Aditi SarkarHighlights The Australian stock market closed on a higher note on Monday The benchmark of the ASX healthcare sector, S&P/ASX 200 Health Care, is up by 2.30% on a QTD basis WFL reported quarter-on-quarter cash receipts growth of 312% T.....
CSL’s (ASX: CSL) Vifor Pharma acquisition se to get delayed, shares fall
May 12, 2022 03:27 PM AEST| By Sukriti NairHighlights CSL Limited share price drops about 1.69% by afternoon today (12 May, 1:PM AEST). CSL has warned of a delay in the Vifor pharma acquisition. CSL shares also track the broader market and healthcare sector downtrend. Shares of th.....
Beamtree (ASX:BMT) signs US$7M contract with Ampath; shares surge
May 10, 2022 01:23 PM AEST| By RitwikaHighlights Beamtree has signed a five-year deal with Ampath for the implementation of its RippleDown software. The total value of the contract is AU$9.7 million. Backed by the announcement, the share price of Beamtree has gained mo.....
PME, MDR, CSL: A look at three ASX healthcare growth stocks
May 08, 2022 12:25 AM AEST| By Aditi SarkarHighlights Growth stocks are shares of the company estimated to increase sales and earnings faster than the market These stocks are likely to provide good price appreciation in the future Growth stocks also serve as a good hedge against inflat...
XPON subsidiary Wondaris expands reach by teaming up with Google CMU
May 06, 2022 05:43 PM AEST| By Aditi SarkarHighlights XPN’s Wondaris platform has teamed up with Google’s CMU program The partnership will allow clients to upload high-value audiences safely through easy and clickable workflow Customers will now be able to deliver marketing.....
3D Printing: A great approach in healthcare innovations
May 05, 2022 07:30 PM AEST| By Aditi SarkarHighlights 3D printing technology is used in developing new surgical cuttings, patient-specific replicas of bones, organs and blood vessels The innovative technology has created long-lasting and better-fitting implants 3D printers that can rep...
Clinuvel (ASX:CUV) shares upbeat results from afamelanotide drug trial
May 04, 2022 01:05 PM AEST| By Aditi SarkarHighlights: CUV has received encouraging outcomes from the first clinical study assessing afamelanotide as a treatment for a life-threatening brain injury. In the clinical study, five out of six patients receiving afamelanotide recovered well i.....
IPD, MX1 & MDR: Three ASX health tech stocks with strong revenue in 3Q
May 04, 2022 11:27 AM AEST| By Aditi SarkarHighlights ImpediMed saw record results for total revenue and SOZO SaaS revenue in Q3. Micro-X achieved good growth in Mobile DR unit sales with expanded network, distributors and inventory on hand. MedAdvisor reported a 96.1% YoY surge in ope.....
AGN, PYC, KZA: An insight into key highlights of healthcare therapeutics from March quarter
May 02, 2022 12:30 PM AEST| By Aditi SarkarHighlights AGN continued preclinical work targeting the potential use of ARG-007 in other kinds of brain injuries PYC initiated GLP toxicology studies in the RP11 program to support IND submission in 2H 2022 Kazia launched an ATM facility in c.....
BOD (ASX:BOD) shares gain attention on quarterly update
April 29, 2022 04:15 PM AEST| By SamtaHighlights BOD Australia has made solid progress towards the commencement of clinical trials and product commercialisation. Cannabis sales increased by 2% from the previous quarter. The company secured Clinical Trial Authorisation from the UK&...
ResMed (ASX:RMD) revenue takes strong leap in FY22 third quarter
April 29, 2022 12:18 PM AEST| By RitwikaHighlights: ResMed released its unaudited Q3 FY22 results today, stating a 14% gain in revenue. ResMed’s earnings per share stand at AU$1.22 per share in the given period. The company will further pay a quarterly dividend wor.....
Why is Starpharma (ASX:SPL) in news today?
April 29, 2022 12:02 PM AEST| By Sonal GoyalHighlights: Starpharma is working closely with LloydsPharmacy to bring VIRALEZE back in the UK by this quarter. Starpharma has recorded AU$3.6 million rise in the cash balance within a quarter. The company has reported receipts of AU$9.6 milli.....
DXB, AT1, JTL: How did these healthcare penny stocks fare in March quarter?
April 28, 2022 08:07 PM AEST| By Aditi SarkarHighlights Penny stocks are generally priced below one dollar DXB has received the Orphan Drug Designation for DMX 200 in both the US and Europe for the FSGS AT1 benefitted from the Omicron wave, and the company sold nearly 550K COVID-19 rapid...
Life360 Inc’s (ASX: 360) subscription revenue rises 63% in FY22
April 27, 2022 07:34 PM AEST| By Aditi SahaHighlights With a 43% yoy (year-on-year) increase in paying circles and a 63% yoy (year-on-year) growth in subscription revenue, Life360’s main business is gaining traction. Core Life360 has a global monthly active user (MAU) base of 38.3.....
Actinogen gets upbeat results from Xanamem trial for Alzheimer’s treatment
April 27, 2022 07:28 PM AEST| By Aditi SarkarHighlights Actinogen Medical receives encouraging results for XanaMIA Part A trial for its lead compound Xanamem The results confirm the potential of Xanamem to improve cognition even in a cognitively normal population Xanamem exhibited a good.....
Advertise your brand on Kalkine Media